4-(N-Hydroxyphenyl)retinamide Can Selectively Induce Apoptosis in Human Epidermoid Carcinoma Cells But Not in Normal Dermal Fibroblasts

REFERENCES

• Bollag W., Matter A. From Vitamin A to Retinoids in Experimental and Clinical Oncology: Achievements, Failures and Outlook. Ann NY Acad. Sci. 1981; 359: 9–23
   PubMed Web of Science ®Google Scholar
• Chan L. N., Zhang S., Shao J., Waikel R., Thompson E. A., Chan T. S. N-(4-Hydroxyphenyl)retinamide Induces Apoptosis in T Lymphoma and T Lymphoblastoid Leukemia Cells. Leuk. Lymphoma 1997; 25(3–4)271–280
   PubMed Web of Science ®Google Scholar
• Wang T. T., Phang J. M. Effect of N-(4-Hydroxyphenyl) retinamide on Apoptosis in Human Breast Cancer Cells. Cancer Lett. 1996; 107(1)65–71
   PubMed Web of Science ®Google Scholar
• Kalemkerian G. P., Slusher R., Ramalingam S., Gadgeel S., Mabry M. Growth Inhibition and Induction of Apoptosis by Fenretinide in Small-Cell Lung Cancer Cell Lines. J. Natl. Cancer Inst. 1995; 87(22)1674–1680
   PubMed Web of Science ®Google Scholar
• Igawa M., Tanabe T., Chodak G. W., Rukstalis D. B. N-(4-Hydroxyphenyl)retinamide Induces Cell Cycle Specific Growth Inhibition in PC3 Cells. Prostate 1994; 24(6)299–305
   PubMed Web of Science ®Google Scholar
• Oridate N., Lotan D., Xu X.-C., Hong W. K., Lotan R. Differential Induction of Apoptosis by All-trans Retinoic Acid and N-(4-Hydroxyphenyl)retinamide in Human Head and Neck Squamous Cell Carcinoma Cell Lines. Clin. Cancer Res. 1996; 2: 855–863
   PubMed Web of Science ®Google Scholar
• Moon R. C., Kelloff G. J., Detrisac C. J., Steele V. E., Thomas C. F., Sigman C. C. Chemoprevention of MNU-induced Mammary Tumors in the Mature Rat by 4-HPR and Tamoxifen. Anticancer Res. 1992; 12(4)1147–1153
   PubMed Web of Science ®Google Scholar
• Becci P. J., Thompson H. J., Sporn M. B., Moon R. C. Retinoid Inhibition of Highly Invasive Urinary Bladder Carcinomas Induced in Mice by N-butyl-N-(4-hydoxybutyl)nitrosamine (OH-BBN). Proc. Am. Assoc. Cancer Res. 1980; 21: 88
   Web of Science ®Google Scholar
• Tamura K., Nakae D., Horiguchi K., Akai H., Kobayashi Y., Andoh N., Satoh H., Denda A., Tsujiuchi T., Yoshiji H., Konishi Y. Inhibition by N-(4-Hydroxy- phenyl)retinamide and All-trans-Retinoic Acid of Exogenous and Endogenous Development of Putative Preneoplastic, Glutathione S-transferase Placental Form-Positive Lesions in the Livers of Rats. Carcinogenesis 1997; 18(11)2133–2141
   PubMed Web of Science ®Google Scholar
• Costa A., De Palo G., Decensi A., Formelli F., Chiesa F., Nava M., Camerini T., Marubini E., Veronesi U. Retinoids in Cancer Chemoprevention. Clinical Trials with the Synthetic Analogue Fenretinide. Ann. NY Acad. Sci. 1995; 768: 148–162
   PubMed Web of Science ®Google Scholar
• Kelloff G. J. Chemoprevention Branch and Agent Development Committee, Division of Cancer Prevention and Control, National Cancer Institute. Clinical Development Plan: N-(4-Hydroxyphenyl)retinamide (4-HPR). J. Cell Biochem. 1994; 20: 176–196
   Google Scholar
• Paulson J. D., Oldham J. W., Preston R. F., Newman D. Lack of Genotoxicity of the Cancer Chemopreventive Agent N-(4-Hydroxyphenyl)retinamide. Fundam. Appl. Toxicol. 1992; 5: 144
   Google Scholar
• Chiesa F., Tradati N., Marazza M., Rossi N., Boracchi P., Mariani L., Formelli F., Giardini R., Costa A., De Palo G. Fenretinide (4-HPR) in Chemoprevention of Oral Leukoplakia. J. Cell Biochem. 1993; 17F(suppl)255–261
   Google Scholar
• De Palo G., Veronesi U., Marubini E., Camerini T., Chiesa F., Nava M., Formelli F., Del Vecchio M., Costa A., Boracchi P. Controlled Clinical Trials with Fenretinide in Breast Cancer, Basal Cell Carcinoma and Oral Leukoplakia [Review]. J. Cell Biochem. Suppl. 1995; 22: 11–17
   PubMedGoogle Scholar
• Twentyman P. R., Luscombe M. A Study of Some Variables in a Tetrazolium Dye (MTT) Based Assay for Cell Growth and Chemosensitivity. Br. J. Cancer 1987; 56: 279–285
   PubMed Web of Science ®Google Scholar
• Bell E., Ivarson B., Merrill C. Production of a Tissue-like Structure by Contraction of Collagen Lattices by Human Fibroblasts of Different Proliferative Potential In Vitro. Proc. Natl. Acad. Sci. USA 1979; 76: 1274–1278
   PubMed Web of Science ®Google Scholar
• Fanjul A. N., Delia D., Pierotti M. A., Rideout D., Qiu J., Pfahl M. 4-Hydroxyphenylretinamide Is a Highly Selective Activator of Retinoid Receptors. J. Biol. Chem. 1996; 271(37)22441–22446
   PubMed Web of Science ®Google Scholar
• Sheikh M. S., Shao Z. M., Li X. S., Ordonez J. V., Conley B. A., Wu S., Dawson M. I., Han Q. X., Chao W. R., Quick T. N-(4-Hydroxyphenyl)retinamide (4-HPR)-mediated Biological Actions Involve Retinoid Receptor-Independent Pathways in Human Breast Carcinoma. Carcinogenesis 1995; 16(10)2477–2486
   PubMed Web of Science ®Google Scholar
• Delia D., Aiello A., Lombardi L., Pelicci P. G., Grignani F., Grignani F., Formelli F., Menard S., Costa A., Veronesi U. N-(4-Hydroxyphenyl)retinamide Induces Apoptosis of Malignant Hemopoietic Cell Lines Including Those Unresponsive to Retinoic Acid. Cancer Res. 1993; 53(24)6036–6041
   PubMed Web of Science ®Google Scholar
• Brigati C., Ferrari N., Megna M., Roncella S., Cutrona G., Tosetti F., Vidali G. A Retinoic Acid Resistant HL-60 Cell Clone Sensitive to N-(4-Hydroxyphenyl)retinamide-mediated Clonal Growth Inhibition. Leuk Lymphoma 1995; 17(1–2)175–180
   PubMed Web of Science ®Google Scholar
• Eicher S. A., Lotan R. Differential Effects of Retinoic Acid and N-(4-Hydroxyphenyl)retinamide on Head and Neck Squamous Cell Carcinoma Cells. Laryngoscope 1996; 106(12 Pt 1)1471–1475
   PubMed Web of Science ®Google Scholar
• Dipietrantonio A., Hsieh T. C., Wu J. M. Differential Effects of Retinoic Acid (RA) and N-(4-Hydroxyphenyl)retinamide (4-HPR) on Cell Growth, Induction of Differentiation, and Changes in p34cdc2, Bcl-2, and Actin Expression in the Human Promyelocytic HL-60 Leukemic Cells. Biochem. Biophys. Res. Commun. 1996; 224(3)837–842
   PubMed Web of Science ®Google Scholar
• Bunk M. J., Telang N. T., Higgins P. J., Traganos F., Sarkar N. H. Effect of N-(4-Hydroxyphenyl)retinamide on Murine Mammary Tumor Cells in Culture. Nutr. Cancer 1985; 7(1&2)105–115
   PubMedGoogle Scholar
• Oridate N., Suzuki S., Higuchi M., Mitchell M. F., Hong W. K., Lotan R. Involvement of Reactive Oxygen Species in N-(4-Hydroxyphenyl)retinamide-induced Apoptosis in Cervical Carcinoma Cells. J. Natl. Canc. Inst. 1997; 89(16)1191–1198
   PubMed Web of Science ®Google Scholar
• Giandomenico V., Andreola F., Rodriguez de la Concepcion M. L., Collins S. J., De Luca L. M. Retinoic Acid and 4-Hydroxyphenylretinamide Induce Growth Inhibition and Tissue Transglutaminase Through Different Signal Transduction Pathways in Mouse Fibroblasts (NIH 3T3 cells). Carcinogenesis 1999; 20(6)1133–1135
   PubMed Web of Science ®Google Scholar